For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can provide sustained relief.

Mindfulness and transcranial direct current stimulation offer therapeutic benefit for reducing situational urgency urinary incontinence symptoms in women.

The Huntington disease Digital Motor Score, derived from smartphone sensor-based motor tests, can improve detection of disease progression.

Fremanezumab vs placebo significantly reduced monthly migraine days and depressive symptoms in patients with migraine and comorbid major depressive disorder.

Dr L’Erario discusses neurologic care for TGD patients, highlighting key challenges, best practices, & steps toward more inclusive treatment.

For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety ...

Hearing loss may cause up to one-third of dementia cases in older adults, making it an important risk factor to address.

Intravenous thrombolysis in patients hospitalized for cervical artery dissection-related acute ischemic stroke increases the likelihood of home discharge.

The FDA has accepted for review the resubmitted NDA for ND0612 for the treatment of motor fluctuations in patients with Parkinson disease.

The FDA has approved Brekiya (dihydroergotamine mesylate) injection for the acute treatment of migraine with or without aura ...

A growing number of firearm suicides in the United States occur outside the home, most commonly in motor vehicles.

Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD).